Literature DB >> 7589841

NIDDM is the major cause of diabetic end-stage renal disease. More evidence from a tri-ethnic community.

J A Pugh1, R A Medina, J C Cornell, S Basu.   

Abstract

Diabetes is the single largest cause of end-stage renal disease (ESRD) in adults in the U.S. Insulin-dependent diabetes mellitus (IDDM) has been recognized for some time as an important cause of ESRD, but non-insulin-dependent diabetes mellitus (NIDDM) has been assumed, until recently, to rarely cause ESRD. The objective of this study is to determine the incidence of treatment of diabetic ESRD by diabetic type for three ethnic/racial groups: non-Hispanic whites, African-Americans, and Mexican-Americans. A population-based incidence cohort was assembled from all dialysis centers in Bexar (San Antonio) and Dallas counties in Texas. All patients with diabetic ESRD beginning dialysis between 1 December 1987 (Bexar) or 1 December 1988 (Dallas) and 31 July 1991 were identified. All non-hispanic whites and African-Americans and a 1/2 random sample of Mexican-Americans were approached for enrollment. Individuals were confirmed to have diabetes using the World Health Organization criteria. Diabetes typing was done using a computerized historical algorithm. Age-specific and age-adjusted incidence rates were obtained by diabetic type and ethnic/racial group. NIDDM causes the majority of diabetic ESRD: 59.5% for non-Hispanic whites, 92.8% for Mexican-Americans, and 84.3% for African-Americans. Mexican-Americans and African-Americans, respectively, have 6.1 and 6.5 times higher incidence of treatment for diabetic ESRD than non-Hispanic whites. NIDDM results in more ESRD than does IDDM. Minorities (African-Americans and Mexican-Americans) are at increased risk, and programs aimed at prevention of NIDDM-related ESRD must focus on them.

Entities:  

Mesh:

Year:  1995        PMID: 7589841     DOI: 10.2337/diab.44.12.1375

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  16 in total

1.  Ethnic disparity in outcomes for pediatric peritoneal dialysis patients in the ESRD Clinical Performance Measures Project.

Authors:  Meredith A Atkinson; Alicia M Neu; Barbara A Fivush; Diane L Frankenfield
Journal:  Pediatr Nephrol       Date:  2007-09-18       Impact factor: 3.714

2.  Losartan and simvastatin inhibit platelet activation in hypertensive patients.

Authors:  Shosaku Nomura; Akira Shouzu; Seitarou Omoto; Mitsushige Nishikawa; Shirou Fukuhara; Toshiji Iwasaka
Journal:  J Thromb Thrombolysis       Date:  2004-12       Impact factor: 2.300

3.  Evaluation of the URiSCAN super cassette ACR semiquantitative urine dipstick for microalbuminuria screening.

Authors:  Min-Chul Cho; Misuk Ji; So Young Kim; Wonho Choe; Woochang Lee; Sail Chun; Won-Ki Min
Journal:  J Clin Lab Anal       Date:  2014-02-27       Impact factor: 2.352

4.  Glucose and angiotensin II-derived endothelial extracellular vesicles regulate endothelial dysfunction via ERK1/2 activation.

Authors:  Kumiko Taguchi; Mari Hida; Haruka Narimatsu; Takayuki Matsumoto; Tsuneo Kobayashi
Journal:  Pflugers Arch       Date:  2016-12-14       Impact factor: 3.657

Review 5.  Susceptibility gene search for nephropathy and related traits in Mexican-Americans.

Authors:  Farook Thameem; Issa A Kawalit; Sharon G Adler; Hanna E Abboud
Journal:  Mol Biol Rep       Date:  2013-09-22       Impact factor: 2.316

Review 6.  Pathophysiology of obesity hypertension.

Authors:  J E Hall
Journal:  Curr Hypertens Rep       Date:  2000-04       Impact factor: 5.369

7.  Overview of type 2 diabetes in Hispanic Americans.

Authors:  I Chukwueke; Z Cordero-Macintyre
Journal:  Int J Body Compos Res       Date:  2010

8.  Evaluation of a SNP map of 6q24-27 confirms diabetic nephropathy loci and identifies novel associations in type 2 diabetes patients with nephropathy from an African-American population.

Authors:  Tennille S Leak; Josyf C Mychaleckyj; Shelly G Smith; Keith L Keene; Candace J Gordon; Pamela J Hicks; Barry I Freedman; Donald W Bowden; Michèle M Sale
Journal:  Hum Genet       Date:  2008-06-17       Impact factor: 4.132

9.  Diabetes, depression, and healthcare utilization among African Americans in primary care.

Authors:  Baqar A Husaini; Pamela C Hull; Darren E Sherkat; Janice S Emerson; Monica T Overton; Clinton Craun; Van A Cain; Robert S Levine
Journal:  J Natl Med Assoc       Date:  2004-04       Impact factor: 1.798

10.  The diabetes prevention program and its global implications.

Authors:  Mark E Molitch; Wilfred Fujimoto; Richard F Hamman; William C Knowler
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.